NORMAN J CLEMENT , RPH, DDS, NORMAN L. CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. IN THE SPIRIT OF WALTER R. CLEMENT BS., MS, MBA. HARVEY JENKINS MD, PH.D., DAVID STEIN, MD IN THE SPIRIT OF C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., EVELYN J. CLEMENT, WALTER F. WRENN III., MD., JULIE KILLINGSWORTH, RENEE BLARE, RPH, DR. TERENCE SASAKI, MD LESLY POMPY MD., CHRISTOPHER RUSSO, MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ARNAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
“…that which has been hidden from you shall be brought to the light…”
DEA and HHS Criminal Forensic Tools Are BASED ON A FOUNDATION OF Junk Science AND NEO-EUGENICS
JULY 2018 vol. 66 Number 4 From the United States Department of Justice it is written:
K. Tate Chambers, Assistant Director Office of Legal Education, inA Primer on Investigating Doctors Who Illegally Prescribe Opioids, writes “Although much of the blame for the current opioid epidemic has been placed at the feet of the medical community for overprescribing opioids, the vast majority of physicians in the United States prescribe opioids to their patients for a legitimate medical purpose.
“Mr. David Abrams is a very tough man with thick skin, and he, like his many other prosecutorial brethren, has been very effective in their courtroom presentations.
However, when one sheds light on their methodologies, which go against the basic foundation of criminal law within the United States and supported by a Foundation of Junk Science, they all run like Cockroaches.”
…norman j. clement rph, dds., terence sasaki, md
However, in spite of efforts at education and raising community awareness of the dangers of overprescribing opioids, there remains a minority of physicians who knowingly prescribe opioids for their personal gain outside of a legitimate medical purpose. The investigation of those physicians is the focus of this article.”
“…SHOW ME THE MAN, AND I’LL FIND YOU THE CRIME…”
Tate explains that “as AUSAs nationwide join General Sessions in this fight against doctors who illegally prescribe opioids, many find themselves confronting this type of case for the first time. What are the investigative tools they can use to investigate the doctors?
How do they tell the bad doctors from those not violating the law? What should they be looking for during the investigation to identify the doctors illegally prescribing opioids? Hopefully, this article will begin to answer some of those questions. It is a primer on these investigations.”
THE PERSECUTION DR. DAVID STEIN, MD
“The War on Drugs has become the War on Doctors in order to attack minority physicians, confiscate assets, provide jobs for defunct government agencies, and make money to justify their existence.”
Tate explains that Attorney General Jeff Sessions pointed out in speeches in Charleston, West Virginia, in September 2017 and other locations, the human cost of the opioid epidemic.
According to Tate, “General Sessions made addressing this epidemic by fighting the overprescribing of opioids by health care professionals a top priority of the Department of Justice. In August 2017, he announced the formation of the Opioid Fraud and Abuse Detection Unit.
This pilot program uses data analytics to identify and prosecute healthcare professionals who are contributing to the prescription opioid epidemic by diverting or dispensing prescription opioids for illegitimate purposes.
The data identifies which physicians are writing opioid prescriptions at a rate that far exceeds other physicians. The data also identifies how many of a doctor’s patients died within sixty days of receiving an opioid prescription. The data also identifies pharmacies that are dispensing disproportionately large amounts of opioids…As part of the program, the Department also funded twelve experienced Assistant United States Attorneys for three years to investigate and prosecute healthcare fraud related to prescription opioids.
“This Justice System abuse has seriously damaged the medical profession, making it unsafe to practice and forcing legitimate patients with legitimate pain — which is 1/3 of the population — to suffer or die.”
The unit’s task is to root out pill mills and prosecute health care professionals who abuse opioid prescriptions.” (Exhibit 133)
“General Sessions warned doctors and pharmacists: [T]oday, we are announcing a new effort to target our federal resources against this epidemic. If you are a doctor illegally prescribing opioids for profit or a pharmacist letting these pills walk out the door and onto our streets based on prescriptions you know were obtained under false pretenses, we are coming after you. We will reverse these devastating trends with every tool we have…
This data analytics team will help us find the tell-tale signs of opioid-related health care fraud by identifying statistical outliers . . . Fraudsters might lie, but the numbers don’t.” General Sessions added: “With these new resources, we will be better positioned to identify, prosecute, and convict some of the individuals contributing to these tens of thousands of deaths a year.
The Department is determined to attack this opioid epidemic, and I believe these resources will make a difference.” The new prosecutors “working with the FBI, DEA, the Department of Health and Human Services, as well as our state and local partners, will help us target and prosecute doctors, pharmacies, and medical providers who are exploiting this epidemic to line their pockets.” (Exhibit 133)
“In September 2017, General Sessions announced grant funding to address the opioid problem: [T]oday, I am announcing that we will be awarding nearly $20 million in federal grants to help law enforcement and public health agencies address prescription drug and opioid abuse. This is an urgent problem and we are making it a top priority.
“The entire basis for the War on Drugs was racist and needs to end. Dr. Zena Crenshaw-Logal, AUI Attorney Advocate“
I believe that these new resources and new efforts will make a difference, bring more criminals to justice and ultimately save lives. And I’m convinced this is a winnable war.” In November 2017, “General Sessions ordered each of the United States Attorneys to designate an Opioid Coordinator in their district.
The role of the coordinator is to work with federal, state, and local law enforcement and prosecutors to identify and prosecute over prescribing and over dispensing cases…We can defeat this evil presence that is killing our people, destroying our families, and weakening our nation.”
In January 2018, “General Sessions announced a DEA surge to combat prescription opioid diversion: I am announcing today that, over the next 45 days, DEA will surge Special Agents, Diversion Investigators, and Intelligence Research Specialists to focus on pharmacies and prescribers who are dispensing unusual or disproportionate amounts of drugs. DEA collects some 80 million transaction reports every year from manufacturers and distributors of prescription drugs.
These reports contain information like distribution figures and inventory.
DEA will aggregate these numbers to find patterns, trends, statistical outliers—and put them into targeting packages. That will help us make more arrests, secure more convictions—and ultimately help us reduce the number of prescription drugs available for Americans to get addicted to or overdose from these dangerous drugs.”
In February 2018, “General Sessions appointed an experienced federal prosecutor to serve as the National Director of Opioid Enforcement and Prevention Efforts at the Department of Justice. He directed her to “help us formulate and implement initiatives, polices, grants, and programs relating to opioids, and coordinate these efforts with law enforcement.”
He also announced the creation of the Prescription Interdiction and Litigation (PIL) Task Force. The PIL Task force includes senior officials from the offices of the Attorney General, the Deputy Attorney General, the Associate Attorney General, the Executive Office for U.S. Attorneys, the Civil Division, the Criminal Division, and the Drug Enforcement Administration.”
General Sessions said, “The PIL Task Force will focus in particular on targeting opioid manufacturers and distributors who have contributed to this epidemic. We will use criminal penalties. We will use civil penalties. We will use whatever tools we have to hold people accountable for breaking our laws.”
General Sessions warned physicians and pharmacists who are breaking the law, “These are not our last steps. We will continue to attack the opioid crisis from every angle. And we will continue to work tirelessly to bring down the number of opioid prescriptions, reduce the number of fatal overdoses, and to protect the American people.”
Tate explains that, “As Benjamin Barron points out in his article, Strategies for Investigators and Prosecutors in Prescription Drug Diversion Cases, “[t]here is little (if any) meaningful distinction between acting with a ‘legitimate medical purpose’ and acting within ‘the usual course of practice,’ and multiple cases have upheld indictments or jury instruction that include one term but not the other.”
Barron also points out that, “[i]n the context of medical practice, ‘dispensing’ includes the act of filling a prescription or directly giving a drug to a patient, while ‘distribution’ and ‘delivery’ include the act of writing a prescription.”
Barron describes the PDMP as “a government-run electronic database tracking prescriptions for controlled drugs statewide, based on information submitted by the dispensing pharmacy or doctor to a central clearinghouse …[G]enerally, the data kept . . . includes the drug prescribed (type, strength, and quantity), the prescribing doctor, the patient, and the pharmacy at which the prescription is filled…
Barron sets out the use of PDMP records: PDMP data will show whether the doctor is prescribing repeating patterns of the same controlled drugs or cocktails (including cocktails like opiates and sedatives that, when taken together, are particularly dangerous); whether the dosages are uniform (evidencing a lack of individualized treatment or drug strengths in excess of ordinary treatment); and whether the drugs are being filled at only one or a select set of pharmacies (reflecting collusion).”
FOR NOW, YOU ARE WITHIN